Click image to enlarge
The Muscle Injury Panel 3 (mouse) Kit has been validated for the quantitative determination of endogenouse cardiac troponin I (cTnI), fatty acid binding protein 3 (FABP3), myosin light chain 3 (Myl3), and skeletal troponin I (sTnI) in mouse serum and plasma. The Muscle Injury Panel 3 (mouse) Kit is designed to distinguish myocardial damage from damage to skeletal muscle and other tissues.
Troponin is a heterodimer that regulates muscle contraction in skeletal and cardiac muscle. Troponin acts with intracellular calcium to control the interaction of actin and myosin filaments in striated muscle fibers. When muscle tissue is damaged, the troponin-tropomyosin complex breaks down and troponin I is released into the blood. cTnI can be readily distinguished from its skeletal muscle analogs making it an excellent biomarker for myocardial injury and cardiotoxicity. FABP3 is a monomeric protein that modulates the uptake of fatty acids in cells. Heart-type fatty acid binding protein is released into circulation after myocardial ischemia and necrosis. FABP3 is mostly present in heart and skeletal muscle but can also be found in brain, liver, and small intestine. Myl3 is an essential light chain of the myosin molecule found in cardiac and slow-twitch skeletal muscle. After damage to muscle tissue, myosin breaks down and Myl3 becomes elevated in the blood. Myl3 can be used in conjunction with other toxicity biomarkers to confirm cardiac and slow twitch skeletal muscle injury.
-
-
Specifications
-
Kit Contents
-
Documentation
-
References
Application(s)
|
|
Cardiac Biomarkers
,
Cardiac Injury
,
Muscle Injury
,
Toxicology
,
Cardiovascular
|
|
Analyte(s)
|
|
FABP3/H-FABP, Myl3/CMLC1, Troponin I (cardiac), Troponin I (fast-twitch)
|
|
Species
|
|
Mouse
|
|
Instrument(s)
|
|
SECTOR Imager 2400
,
MESO SECTOR S 600MM
,
SECTOR Imager 6000
,
MESO QuickPlex SQ 120MM
,
MESO QuickPlex SQ 120
,
MESO SECTOR S 600
|
|
Plate Type
|
|
96-well
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
Storage Condition
|
|
Multi-Component
|
|
Schedule B Code
|
|
3822.19.0000
|
|
Product Description
|
Storage
|
Quantity per Kit
|
DTT, 1.0 mL
|
≤-10 °C
|
1 vial
|
|
EDTA, 0.5 M pH 8.0, 4.0 mL
|
RT
|
1 vial
|
|
SULFO-TAG Anti-FABP3 Antibody
|
2-8 °C
|
1 vial (1 vial)
|
|
SULFO-TAG Anti-mouse cTnI Antibody
|
2-8 °C
|
1 vial (1 vial)
|
|
SULFO-TAG Anti-mouse Skeletal Troponin I Antibody
|
2-8 °C
|
1 vial (1 vial)
|
|
SULFO-TAG Anti-mouse Myl3 Antibody
|
2-8 °C
|
1 vial (1 vial)
|
|
Muscle Injury Panel 3 Calibrator Blend
|
≤-70 °C
|
1 vial (20 μL)
|
|
Muscle Injury Panel 3 (Mouse) Plate
|
2-8 °C
|
1 each (1 each)
|
|
|
≤-10 °C
|
1 bottle (25 mL)
|
|
|
≤-10 °C
|
2 bottle (5 mL)
|
|
|
RT
|
1 bottle (50 mL)
|
|
Product Description
|
Storage
|
Quantity per Kit
|
DTT, 1.0 mL
|
≤-10 °C
|
1 vial
|
|
EDTA, 0.5 M pH 8.0, 4.0 mL
|
RT
|
1 vial
|
|
SULFO-TAG Anti-FABP3 Antibody
|
2-8 °C
|
1 vial
|
|
SULFO-TAG Anti-mouse cTnI Antibody
|
2-8 °C
|
1 vial
|
|
SULFO-TAG Anti-mouse Skeletal Troponin I Antibody
|
2-8 °C
|
1 vial
|
|
SULFO-TAG Anti-mouse Myl3 Antibody
|
2-8 °C
|
1 vial
|
|
Muscle Injury Panel 3 Calibrator Blend
|
≤-70 °C
|
5 vial (20 μL)
|
|
Muscle Injury Panel 3 (Mouse) Plate
|
2-8 °C
|
5 each (1 each)
|
|
|
≤-10 °C
|
1 bottle (25 mL)
|
|
|
≤-10 °C
|
1 bottle (50 mL)
|
|
|
RT
|
1 bottle (50 mL)
|
|
Product Description
|
Storage
|
Quantity per Kit
|
DTT, 1.0 mL
|
≤-10 °C
|
5 vial
|
|
EDTA, 0.5 M pH 8.0, 4.0 mL
|
RT
|
5 vial
|
|
SULFO-TAG Anti-FABP3 Antibody
|
2-8 °C
|
5 vial
|
|
SULFO-TAG Anti-mouse cTnI Antibody
|
2-8 °C
|
5 vial
|
|
SULFO-TAG Anti-mouse Skeletal Troponin I Antibody
|
2-8 °C
|
5 vial
|
|
SULFO-TAG Anti-mouse Myl3 Antibody
|
2-8 °C
|
5 vial
|
|
Muscle Injury Panel 3 Calibrator Blend
|
≤-70 °C
|
25 vial (20 μL)
|
|
Muscle Injury Panel 3 (Mouse) Plate
|
2-8 °C
|
25 each (1 each)
|
|
|
≤-10 °C
|
5 bottle (25 mL)
|
|
|
≤-10 °C
|
5 bottle (50 mL)
|
|
|
RT
|
5 bottle (50 mL)
|
|
Product Inserts
|
|
|
Datasheets
|
|
|
Certificate of analysis
|
|
|
SDS
|
|
|
Title
|
Journal
|
Year
|
|
A sensitive and specific quantitation method for determination of serum cardiac Myosin binding protein-C by electrochemiluminescence immunoassay.
|
|
|
|
Doxycycline reduces cardiac Matrix Metalloproteinase-2 activity but does not ameliorate myocardial dysfunction during reperfusion in coronary artery bypass patients undergoing cardiopulmonary bypass.
|
|
|
|
Dystrophin-deficient cardiomyocytes derived from human urine: New biologic reagents for drug discovery.
|
|
|
|
Mild oxidative damage in the diabetic rat heart is attenuated by glyoxalase-1 overexpression.
|
|
|
|
Biomarker panel of cardiac and skeletal muscle troponins, fatty acid binding protein 3 and myosin light chain 3 for the accurate diagnosis of cardiotoxicity and musculoskeletal toxicity in rats.
|
|
|
|
View All
|
Order Details
Catalog No
Size
Price in USD
Qty
Meso Scale Japan 株式会社